BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 30268449)

  • 1. Current efforts in research of pleural mesothelioma-An analysis of the ClinicalTrials.gov registry.
    Süveg K; Putora PM; Berghmans T; Glatzer M; Kovac V; Cihoric N
    Lung Cancer; 2018 Oct; 124():12-18. PubMed ID: 30268449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates in the diagnosis and treatment of malignant pleural mesothelioma.
    Katzman D; Sterman DH
    Curr Opin Pulm Med; 2018 Jul; 24(4):319-326. PubMed ID: 29553973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy for malignant pleural mesothelioma. Current status and future prospects.
    Wong RM; Ianculescu I; Sharma S; Gage DL; Olevsky OM; Kotova S; Kostic MN; Grundfest WS; Hou D; Cameron RB
    Am J Respir Cell Mol Biol; 2014 May; 50(5):870-5. PubMed ID: 24450537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in treatment of mesothelioma.
    Maggioni C; Barletta G; Rijavec E; Biello F; Gualco E; Grossi F
    Expert Opin Pharmacother; 2016 Jun; 17(9):1197-205. PubMed ID: 27055148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-tumor immunotherapy in malignant pleural mesothelioma].
    Scherpereel A; Willemin MC; Wasielewski E; Dhalluin X
    Rev Mal Respir; 2018 Apr; 35(4):465-476. PubMed ID: 29415822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a role for immunotherapy in malignant pleural mesothelioma?
    Tartarone A; Lerose R; Aieta M
    Med Oncol; 2018 May; 35(7):98. PubMed ID: 29845408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Concepts in the Treatment of Malignant Pleural Mesothelioma.
    Wald O; Sugarbaker DJ
    Annu Rev Med; 2018 Jan; 69():365-377. PubMed ID: 29029582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
    Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
    Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapleural immunotherapy: An update on emerging treatment strategies for pleural malignancy.
    Murthy V; Katzman D; Sterman DH
    Clin Respir J; 2019 May; 13(5):272-279. PubMed ID: 30810270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase II Trial of Nivolumab With Chemotherapy Followed by Maintenance Nivolumab in Patients With Pleural Mesothelioma After Surgery: The NICITA Study Protocol.
    Shah R; Klotz LV; Chung I; Feißt M; Schneider MA; Riedel J; Bischoff H; Eichhorn ME; Thomas M
    Clin Lung Cancer; 2021 Mar; 22(2):142-146. PubMed ID: 33158765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal Therapy of Advanced Stage Mesothelioma.
    Disselhorst MMJ; Burgers SJA; Baas P
    Curr Treat Options Oncol; 2017 Aug; 18(8):48. PubMed ID: 28681207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chinese guideline for clinical diagnosis and treatment of malignant pleural mesothelioma (2021 Edition)].
    Multidisciplinary Committee of Oncology, Chinese Physicians Association
    Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):383-394. PubMed ID: 33902201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New therapeutic strategies for malignant pleural mesothelioma.
    Bonelli MA; Fumarola C; La Monica S; Alfieri R
    Biochem Pharmacol; 2017 Jan; 123():8-18. PubMed ID: 27431778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant pleural mesothelioma.
    Chen SE; Pace MB
    Am J Health Syst Pharm; 2012 Mar; 69(5):377-85. PubMed ID: 22345416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current treatments and trials in malignant pleural mesothelioma.
    Bibby AC; Maskell NA
    Clin Respir J; 2018 Jul; 12(7):2161-2169. PubMed ID: 30129116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy and malignant mesothelioma: clinical perspectives].
    Grégoire M; Ebstein F
    Bull Cancer; 2007 Jan; 94(1):23-31. PubMed ID: 17237002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A catalogue of treatment and technologies for malignant pleural mesothelioma.
    Schunselaar LM; Quispel-Janssen JM; Neefjes JJ; Baas P
    Expert Rev Anticancer Ther; 2016; 16(4):455-63. PubMed ID: 26943000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local and systemic therapies for malignant pleural mesothelioma.
    Gomez D; Tsao AS
    Curr Treat Options Oncol; 2014 Dec; 15(4):683-99. PubMed ID: 25266654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal management of malignant pleural mesothelioma: where are we today?
    Van Schil PE; Opitz I; Weder W; De Laet C; Domen A; Lauwers P; Hendriks JM; Van Meerbeeck JP
    Eur Respir J; 2014 Sep; 44(3):754-64. PubMed ID: 24525443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malign pleural mesothelioma - so far an undefeated tumor].
    Kolek V
    Vnitr Lek; 2018; 63(11):884-888. PubMed ID: 29303291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.